Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma

Research output: Contribution to journalArticle

154 Citations (Scopus)

Abstract

A number of clinical studies have demonstrated the prognostic significance of angiogenesis and angiogenic growth factors in solid tumours; however, very little is known about the relevance of these parameters in haematological malignancies. We evaluated circulating levels of angiogenic growth factors and endostatin in 36 non-Hodgkin's lymphoma (NHL) patients. Baseline vascular endothelial growth factor (VEGF) levels of patients in complete remission (CR) after a median follow-up of 21 months were significantly lower than those of patients with progressive disease (P=0.016). Event-free survival (EFS) rate was significantly higher in patients who had baseline VEGF and basic-fibroblast growth factor (b.FGF) levels below the median values of 147 and 19.5 pg/ml (P=0.018 and 0.039 by log-rank test, respectively). Conversely, the levels of endostatin, angiogenin and leptin were not different in CR patients compared to relapsed patients and did not correlate with EFS. Our data suggest that b-FGF and, particularly, VEGF might be considered prognostic factors in NHI, staging and management.

Original languageEnglish
Pages (from-to)504-509
Number of pages6
JournalBritish Journal of Haematology
Volume106
Issue number2
DOIs
Publication statusPublished - 1999

Fingerprint

Endostatins
Angiogenesis Inducing Agents
Non-Hodgkin's Lymphoma
Intercellular Signaling Peptides and Proteins
Vascular Endothelial Growth Factor A
Disease-Free Survival
Fibroblast Growth Factor 2
Hematologic Neoplasms
Leptin
Survival Rate

Keywords

  • Angiogenesis
  • Angiogenic growth factors
  • Endostatin
  • Non-Hodgkin's lymphoma

ASJC Scopus subject areas

  • Hematology

Cite this

Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma. / Bertolini, Francesco; Paolucci, Mara; Peccatori, Fedro; Cinieri, Saverio; Agazzi, Alberto; Ferrucci, Pier Francesco; Cocorocchio, Emilia; Goldhirsch, Aron; Martinelli, Giovanni.

In: British Journal of Haematology, Vol. 106, No. 2, 1999, p. 504-509.

Research output: Contribution to journalArticle

@article{e3f7f49fdb3246229604a7cb964a6bb9,
title = "Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma",
abstract = "A number of clinical studies have demonstrated the prognostic significance of angiogenesis and angiogenic growth factors in solid tumours; however, very little is known about the relevance of these parameters in haematological malignancies. We evaluated circulating levels of angiogenic growth factors and endostatin in 36 non-Hodgkin's lymphoma (NHL) patients. Baseline vascular endothelial growth factor (VEGF) levels of patients in complete remission (CR) after a median follow-up of 21 months were significantly lower than those of patients with progressive disease (P=0.016). Event-free survival (EFS) rate was significantly higher in patients who had baseline VEGF and basic-fibroblast growth factor (b.FGF) levels below the median values of 147 and 19.5 pg/ml (P=0.018 and 0.039 by log-rank test, respectively). Conversely, the levels of endostatin, angiogenin and leptin were not different in CR patients compared to relapsed patients and did not correlate with EFS. Our data suggest that b-FGF and, particularly, VEGF might be considered prognostic factors in NHI, staging and management.",
keywords = "Angiogenesis, Angiogenic growth factors, Endostatin, Non-Hodgkin's lymphoma",
author = "Francesco Bertolini and Mara Paolucci and Fedro Peccatori and Saverio Cinieri and Alberto Agazzi and Ferrucci, {Pier Francesco} and Emilia Cocorocchio and Aron Goldhirsch and Giovanni Martinelli",
year = "1999",
doi = "10.1046/j.1365-2141.1999.01547.x",
language = "English",
volume = "106",
pages = "504--509",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley & Sons, Ltd (10.1111)",
number = "2",

}

TY - JOUR

T1 - Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma

AU - Bertolini, Francesco

AU - Paolucci, Mara

AU - Peccatori, Fedro

AU - Cinieri, Saverio

AU - Agazzi, Alberto

AU - Ferrucci, Pier Francesco

AU - Cocorocchio, Emilia

AU - Goldhirsch, Aron

AU - Martinelli, Giovanni

PY - 1999

Y1 - 1999

N2 - A number of clinical studies have demonstrated the prognostic significance of angiogenesis and angiogenic growth factors in solid tumours; however, very little is known about the relevance of these parameters in haematological malignancies. We evaluated circulating levels of angiogenic growth factors and endostatin in 36 non-Hodgkin's lymphoma (NHL) patients. Baseline vascular endothelial growth factor (VEGF) levels of patients in complete remission (CR) after a median follow-up of 21 months were significantly lower than those of patients with progressive disease (P=0.016). Event-free survival (EFS) rate was significantly higher in patients who had baseline VEGF and basic-fibroblast growth factor (b.FGF) levels below the median values of 147 and 19.5 pg/ml (P=0.018 and 0.039 by log-rank test, respectively). Conversely, the levels of endostatin, angiogenin and leptin were not different in CR patients compared to relapsed patients and did not correlate with EFS. Our data suggest that b-FGF and, particularly, VEGF might be considered prognostic factors in NHI, staging and management.

AB - A number of clinical studies have demonstrated the prognostic significance of angiogenesis and angiogenic growth factors in solid tumours; however, very little is known about the relevance of these parameters in haematological malignancies. We evaluated circulating levels of angiogenic growth factors and endostatin in 36 non-Hodgkin's lymphoma (NHL) patients. Baseline vascular endothelial growth factor (VEGF) levels of patients in complete remission (CR) after a median follow-up of 21 months were significantly lower than those of patients with progressive disease (P=0.016). Event-free survival (EFS) rate was significantly higher in patients who had baseline VEGF and basic-fibroblast growth factor (b.FGF) levels below the median values of 147 and 19.5 pg/ml (P=0.018 and 0.039 by log-rank test, respectively). Conversely, the levels of endostatin, angiogenin and leptin were not different in CR patients compared to relapsed patients and did not correlate with EFS. Our data suggest that b-FGF and, particularly, VEGF might be considered prognostic factors in NHI, staging and management.

KW - Angiogenesis

KW - Angiogenic growth factors

KW - Endostatin

KW - Non-Hodgkin's lymphoma

UR - http://www.scopus.com/inward/record.url?scp=0032845702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032845702&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2141.1999.01547.x

DO - 10.1046/j.1365-2141.1999.01547.x

M3 - Article

VL - 106

SP - 504

EP - 509

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 2

ER -